BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Harvard Business School
Cipla
Chubb
Colorcon
US Department of Justice
Chinese Patent Office
McKesson
AstraZeneca

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,565,473

« Back to Dashboard

Summary for Patent: 5,565,473
Title: Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
Abstract:Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
Inventor(s): Belley; Michel L. (Pierrefonds, CA), Leger; Serge (Dollard des Ormeaux, CA), Labelle; Marc (Ville d'Ile Perrot, CA), Roy; Patrick (Pierrefonds, CA), Xiang; Yi B. (Pierrefonds, CA), Guay; Daniel (Montreal, CA)
Assignee: Merck Frosst Canada, Inc. (Kirkland, CA)
Application Number:08/392,592
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,565,473

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,565,473

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 165088 ➤ Subscribe
Australia 639610 ➤ Subscribe
Australia 8579491 ➤ Subscribe
Brazil 1100383 ➤ Subscribe
Canada 2053209 ➤ Subscribe
China 1046711 ➤ Subscribe
China 1061407 ➤ Subscribe
Czechoslovakia 9103095 ➤ Subscribe
Cyprus 2094 ➤ Subscribe
Czech Republic 281274 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Medtronic
Federal Trade Commission
AstraZeneca
Argus Health
Merck
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot